조아제약
034940KOSDAQ61.1 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Joa Pharmaceutical, established in 1988, primarily engages in the production and sale of general pharmaceuticals, health functional foods, and is developing pet pharmaceuticals and nutritional supplements. It operates a nationwide pharmacy franchise, Medipham, and supplies over 200 products, including liver disease treatment drug Hepatos, memory improvement drug Joa Baiton, and children's health beverage Jalketon. The company has been exporting its products to 23 countries, including Vietnam, China, and the U.S., since 1995.
Number of Employees
243people
Average Salary
62.4M KRW
Score Calculation Basis
Detailed Financial Score
Lower than industry avg (good)
Well below industry avg
Half of industry avg (excellent)
Avg ▼2.9% (2-year basis)
Avg ▼4.8% (2-year basis)
Avg ROE -28.1% (declining, 3yr)
Detailed News Sentiment
- Positive조아제약 상반기 순이익 흑자 전환…하반기 '가레오·더마'로 비상 예.....
조아제약의 상반기 흑자 전환은 원가 절감과 주력 제품 판매 호조로 인한 경영 효율화 성과를 반영하며 긍정적 전망을 제시한다.
- Neutral[바이오스냅] 식약처, 식품안전영양교육 성과발표회
조아제약 관련 내용이 직접적으로 언급되지 않아 시장 영향을 판단하기 어렵다.
- Positive조아제약, 이담 소화제 '가레오액' 3년 만에 재출시
조아제약의 이담 소화제 '가레오액' 재출시로 인해 제품 경쟁력 강화 및 매출 증대 기대.
Detailed Momentum
Near 52w high (88%, uptrend)
1m +428.18% (strong rise)
Volume dry-up
Detailed Disclosure
- Neutral주권매매거래정지해제 (액면병합 주권 변경상장)2026-08-26
- Neutral반기보고서 (2026.06)2026-08-14
